Coherus BioSciences IncNASDAQ:CHRS
- LAST PRICE1.2100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.2000/ 50
- Ask / Lots1.3000/ 5
- Open / Previous Close--- / 1.2100
- Day Range---
- 52 Week Range
- Volume814
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CHRS |
|---|---|---|
| 09:32 ET | 92422 | 1.1492 |
| 09:33 ET | 86872 | 1.1508 |
| 09:35 ET | 143367 | 1.16 |
| 09:37 ET | 74485 | 1.1646 |
| 09:39 ET | 119160 | 1.175 |
| 09:42 ET | 31176 | 1.1713 |
| 09:44 ET | 258149 | 1.15 |
| 09:46 ET | 41521 | 1.1588 |
| 09:48 ET | 24593 | 1.15 |
| 09:50 ET | 43346 | 1.1694 |
| 09:51 ET | 65938 | 1.19 |
| 09:53 ET | 133213 | 1.19 |
| 09:55 ET | 115896 | 1.2 |
| 09:57 ET | 35876 | 1.21 |
| 10:00 ET | 66760 | 1.195 |
| 10:02 ET | 20974 | 1.195 |
| 10:04 ET | 53338 | 1.2 |
| 10:06 ET | 42649 | 1.2 |
| 10:08 ET | 38367 | 1.2 |
| 10:09 ET | 111691 | 1.2292 |
| 10:11 ET | 65428 | 1.249 |
| 10:13 ET | 7420 | 1.24 |
| 10:15 ET | 332793 | 1.269 |
| 10:18 ET | 121704 | 1.3 |
| 10:20 ET | 101528 | 1.292 |
| 10:22 ET | 105772 | 1.3188 |
| 10:24 ET | 100935 | 1.31 |
| 10:26 ET | 76722 | 1.335 |
| 10:27 ET | 29029 | 1.3215 |
| 10:29 ET | 57529 | 1.31 |
| 10:31 ET | 18482 | 1.3201 |
| 10:33 ET | 19136 | 1.325 |
| 10:36 ET | 421434 | 1.2501 |
| 10:38 ET | 34677 | 1.265 |
| 10:40 ET | 72143 | 1.2799 |
| 10:42 ET | 43799 | 1.285 |
| 10:44 ET | 32228 | 1.2759 |
| 10:45 ET | 63643 | 1.29 |
| 10:47 ET | 36954 | 1.285 |
| 10:49 ET | 218398 | 1.255 |
| 10:51 ET | 80998 | 1.2799 |
| 10:54 ET | 131223 | 1.315 |
| 10:56 ET | 19492 | 1.31 |
| 10:58 ET | 31344 | 1.3094 |
| 11:00 ET | 12766 | 1.29 |
| 11:02 ET | 26965 | 1.305 |
| 11:03 ET | 3863 | 1.305 |
| 11:05 ET | 28195 | 1.295 |
| 11:07 ET | 5793 | 1.2905 |
| 11:09 ET | 6669 | 1.295 |
| 11:12 ET | 2159 | 1.2947 |
| 11:14 ET | 8740 | 1.29 |
| 11:16 ET | 7514 | 1.295 |
| 11:18 ET | 8178 | 1.2905 |
| 11:20 ET | 15422 | 1.2932 |
| 11:21 ET | 7075 | 1.295 |
| 11:23 ET | 22350 | 1.295 |
| 11:25 ET | 57889 | 1.31 |
| 11:27 ET | 9215 | 1.3001 |
| 11:30 ET | 16335 | 1.285 |
| 11:32 ET | 27259 | 1.285 |
| 11:34 ET | 5417 | 1.2842 |
| 11:36 ET | 4697 | 1.285 |
| 11:38 ET | 946 | 1.2835 |
| 11:39 ET | 5195 | 1.28 |
| 11:41 ET | 1060 | 1.285 |
| 11:43 ET | 2920 | 1.28 |
| 11:45 ET | 19436 | 1.2717 |
| 11:48 ET | 8743 | 1.275 |
| 11:50 ET | 30941 | 1.28 |
| 11:52 ET | 300 | 1.2876 |
| 11:54 ET | 67160 | 1.315 |
| 11:56 ET | 15506 | 1.315 |
| 11:57 ET | 4893 | 1.3167 |
| 11:59 ET | 17571 | 1.3195 |
| 12:01 ET | 3262 | 1.3187 |
| 12:03 ET | 4921 | 1.3195 |
| 12:06 ET | 12527 | 1.315 |
| 12:08 ET | 2155 | 1.3103 |
| 12:10 ET | 1395 | 1.31 |
| 12:12 ET | 31926 | 1.3105 |
| 12:14 ET | 18775 | 1.31 |
| 12:15 ET | 29223 | 1.3 |
| 12:17 ET | 12275 | 1.3 |
| 12:19 ET | 2069 | 1.3 |
| 12:21 ET | 20087 | 1.3 |
| 12:24 ET | 12478 | 1.305 |
| 12:26 ET | 126442 | 1.3 |
| 12:28 ET | 1002 | 1.3092 |
| 12:30 ET | 200 | 1.305 |
| 12:32 ET | 9286 | 1.295 |
| 12:33 ET | 5844 | 1.3 |
| 12:35 ET | 42144 | 1.3121 |
| 12:37 ET | 55454 | 1.3298 |
| 12:39 ET | 15600 | 1.3204 |
| 12:42 ET | 5300 | 1.325 |
| 12:44 ET | 11398 | 1.325 |
| 12:46 ET | 32664 | 1.3304 |
| 12:48 ET | 41118 | 1.329 |
| 12:50 ET | 8748 | 1.3205 |
| 12:51 ET | 100323 | 1.315 |
| 12:53 ET | 1745 | 1.315 |
| 12:55 ET | 52632 | 1.3105 |
| 01:00 ET | 1200 | 1.315 |
| 01:02 ET | 70582 | 1.32 |
| 01:04 ET | 41855 | 1.305 |
| 01:06 ET | 500 | 1.305 |
| 01:08 ET | 8633 | 1.3 |
| 01:09 ET | 56669 | 1.29 |
| 01:11 ET | 6667 | 1.295 |
| 01:13 ET | 2642 | 1.2801 |
| 01:15 ET | 97659 | 1.2801 |
| 01:18 ET | 6900 | 1.28 |
| 01:20 ET | 702 | 1.2777 |
| 01:22 ET | 52507 | 1.265 |
| 01:24 ET | 700 | 1.26 |
| 01:26 ET | 55281 | 1.25 |
| 01:29 ET | 11000 | 1.25 |
| 01:31 ET | 26237 | 1.2412 |
| 01:33 ET | 24410 | 1.2696 |
| 01:36 ET | 965 | 1.2692 |
| 01:38 ET | 466 | 1.265 |
| 01:40 ET | 10950 | 1.2696 |
| 01:42 ET | 23668 | 1.275 |
| 01:44 ET | 325 | 1.275 |
| 01:45 ET | 24160 | 1.28 |
| 01:47 ET | 21830 | 1.29 |
| 01:49 ET | 382 | 1.29 |
| 01:51 ET | 700 | 1.29 |
| 01:54 ET | 900 | 1.28 |
| 01:56 ET | 30568 | 1.2901 |
| 02:00 ET | 29770 | 1.295 |
| 02:02 ET | 8662 | 1.29 |
| 02:03 ET | 11650 | 1.29 |
| 02:05 ET | 6837 | 1.29 |
| 02:07 ET | 11950 | 1.29 |
| 02:09 ET | 7672 | 1.29 |
| 02:12 ET | 3512 | 1.295 |
| 02:14 ET | 33008 | 1.315 |
| 02:16 ET | 18835 | 1.3137 |
| 02:18 ET | 12619 | 1.315 |
| 02:20 ET | 39434 | 1.305 |
| 02:21 ET | 14160 | 1.315 |
| 02:23 ET | 27393 | 1.31 |
| 02:25 ET | 21670 | 1.316 |
| 02:27 ET | 20465 | 1.3 |
| 02:30 ET | 2010 | 1.305 |
| 02:32 ET | 13280 | 1.305 |
| 02:34 ET | 11456 | 1.305 |
| 02:36 ET | 14293 | 1.2993 |
| 02:38 ET | 38849 | 1.3 |
| 02:39 ET | 22618 | 1.29 |
| 02:41 ET | 37212 | 1.29 |
| 02:43 ET | 7489 | 1.3 |
| 02:45 ET | 20859 | 1.3 |
| 02:48 ET | 20960 | 1.29 |
| 02:50 ET | 28383 | 1.29 |
| 02:52 ET | 54361 | 1.31 |
| 02:54 ET | 162215 | 1.2912 |
| 02:56 ET | 15300 | 1.2999 |
| 02:57 ET | 4372 | 1.3 |
| 02:59 ET | 500 | 1.295 |
| 03:01 ET | 46540 | 1.295 |
| 03:03 ET | 5800 | 1.295 |
| 03:06 ET | 29624 | 1.285 |
| 03:08 ET | 4341 | 1.285 |
| 03:10 ET | 18997 | 1.29 |
| 03:12 ET | 24103 | 1.29 |
| 03:14 ET | 545 | 1.295 |
| 03:15 ET | 3667 | 1.2912 |
| 03:17 ET | 46134 | 1.28 |
| 03:19 ET | 16916 | 1.28 |
| 03:21 ET | 11309 | 1.28 |
| 03:24 ET | 40269 | 1.275 |
| 03:26 ET | 29040 | 1.275 |
| 03:28 ET | 2121 | 1.275 |
| 03:30 ET | 3173 | 1.28 |
| 03:32 ET | 7000 | 1.2771 |
| 03:33 ET | 7172 | 1.285 |
| 03:35 ET | 15845 | 1.28 |
| 03:37 ET | 41759 | 1.2612 |
| 03:39 ET | 492 | 1.2601 |
| 03:42 ET | 889 | 1.265 |
| 03:44 ET | 7370 | 1.269 |
| 03:46 ET | 2810 | 1.2613 |
| 03:48 ET | 23394 | 1.26 |
| 03:50 ET | 75338 | 1.25 |
| 03:51 ET | 58414 | 1.24 |
| 03:53 ET | 23301 | 1.24 |
| 03:55 ET | 59901 | 1.235 |
| 03:57 ET | 44818 | 1.23 |
| 04:00 ET | 359426 | 1.21 |
Nov 8, 2024
DJ Coherus BioSciences Is Maintained at Outperform by Baird, from 7:38AM ET on Friday Nov 08, 2024 by Dow Jones
7:38AM ET on Friday Nov 08, 2024 by Dow Jones
Nov 7, 2024
DJ Coherus BioSciences Price Target Maintained With a $12.00/Share by HC Wainwright & Co., from 6:34AM ET on Thursday Nov 07, 2024 by Dow Jones
6:34AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 6, 2024
Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update, from 4:01PM ET on Wednesday Nov 06, 2024 by Dow Jones
4:01PM ET on Wednesday Nov 06, 2024 by Dow Jones*DJ Coherus BioSciences 3Q Loss/Shr 9c >CHRS, from 4:01PM ET on Wednesday Nov 06, 2024 by Dow Jones
4:01PM ET on Wednesday Nov 06, 2024 by Dow Jones
Oct 30, 2024
Coherus to Report Third Quarter 2024 Financial Results on November 6, 2024, from 4:20PM ET on Wednesday Oct 30, 2024 by Dow Jones
4:20PM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Coherus BioSciences Inc | 125.6M | -13.6x | --- |
Voyager Therapeutics Inc | 308.9M | 9.8x | --- |
Ginkgo Bioworks Holdings Inc | 391.2M | -0.6x | --- |
Amarin Corporation PLC | 225.7M | -5.5x | --- |
Revance Therapeutics Inc | 391.3M | -2.0x | --- |
Vanda Pharmaceuticals Inc | 296.8M | -17.9x | -37.98% |
Company Information
Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the research, development and commercialization of immunotherapies to treat cancer. The Company’s immuno-oncology pipeline includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer. Casdozokitug is an IL-27 antagonistic antibody, which is being evaluated in two ongoing clinical studies: a Phase I/II study in advanced solid tumors and a Phase II study in hepatocellular carcinoma. CHS-114 is a highly selective, cytolytic anti-CCR8 antibody, which is in a Phase I study in patients with advanced solid tumors. CHS-1000 is a preclinical candidate targeting immune-suppressive mechanisms via the pathway ILT4. It markets LOQTORZI (toripalimab-tpzi), a PD-1 inhibitor, and UDENYCA (pegfilgrastim-cbqv), a biosimilar of Neulasta.
Contact Information
- Headquarters
- C/O DENNIS M. LANFEAR 201 REDWOOD SHORES PARKWAY, SUITE 200REDWOOD CITY, CA, United States 94065
- Phone
- 650-649-3530
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Dennis Lanfear
- Chief Financial Officer
- Bryan Mcmichael
- Chief Development Officer
- Theresa Lavallee
- Chief Commercial Officer
- Paul Reider
- Lead Independent Director
- Mats Wahlstrom
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $125.6M |
|---|---|
Revenue (TTM) | $304.3M |
Shares Outstanding | 115.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.83 |
EPS | $-0.09 |
Book Value | $-1.72 |
P/E Ratio | -13.6x |
Price/Sales (TTM) | 0.4 |
Price/Cash Flow (TTM) | 25.9x |
Operating Margin | 8.44% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
